2,318 followers
Ophthopedia Update: Safety and tolerability of intravitreal umedaptanib pegol (anti-FGF2) for neovascular age-related macular degeneration (nAMD): a phase 1, open-label study https://t.co/aoLjhHEVNg #Ophthalmology #Eye #Ophthotwitter https://t.co/l8MKxXxer